In addition, in the grading of gliomas, these independent datasets consistently showed that the expression level of ESPL1 has good diagnostic value for the prognosis of low-grade gliomas (Supplementary Figures 4–6A). This evidence concerns the gene ESPL1 and central nervous system cancer.